Clinical Trial Update: Dose Escalation Study Using Ultra-Hypofractionated, Image-Guided, Intensity-Modulated Radiotherapy in Prostate Cancer [Phase 1]

View source ↗

Summary

Phase 1 dose-escalation trial evaluating ultra-hypofractionated, image-guided, intensity-modulated radiotherapy for prostate cancer; currently active but not re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Prostate Cancer, Adenocarcinoma | Phase 1 | Status: ACTIVE_NOT_RECRUITING